1. Theoretical Arguments for the Discounting of Health Consequences

   • Angelina Lazaro

   Current Opinion 21 September 2012 Pages: 943 - 961

   

2. Pharmacoeconomic Considerations in Assessing and Selecting Congestive Heart Failure Therapies

   • Emile Levy
   • Pierre Levy

   Review Article 21 September 2012 Pages: 963 - 977

   

3. Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in the Secondary Prevention of Acute Coronary Syndrome

   • Max Brosa
   • Carlos Rubio-Terrés
   • Jenaro Froufe

   Original Research Article 21 September 2012 Pages: 979 - 987

   

4. Insulin Lispro

   • Christopher J. Dunn
   • Greg L. Plosker

   Adis Pharmacoeconomic Drug Evaluation 21 September 2012 Pages: 989 - 1025